User profiles for Jeffrey Seow
 | Jeffrey SeowKings College London Verified email at kcl.ac.uk Cited by 5180 |
[HTML][HTML] Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…
[HTML][HTML] A dynamic COVID-19 immune signature includes associations with poor prognosis
…, S Abdul-Jawad, J Cason, C Mant, J Seow… - Nature medicine, 2020 - nature.com
Improved understanding and management of COVID-19, a potentially life-threatening disease,
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…
[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …
…, TS Hayday, C Graham, J Seow… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…
[HTML][HTML] Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection
Recent reports highlight a new clinical syndrome in children related to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 —multisystem inflammatory syndrome in …
respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 —multisystem inflammatory syndrome in …
[HTML][HTML] Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
[PDF][PDF] The effect of spike mutations on SARS-CoV-2 neutralization
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines show
protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral …
protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral …
[HTML][HTML] The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate
S Gee, M Chandiramani, J Seow, E Pollock… - Nature …, 2021 - nature.com
Despite extensive studies into severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the effect of maternal infection on the neonate is unclear. To investigate this, we …
the effect of maternal infection on the neonate is unclear. To investigate this, we …
[HTML][HTML] Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and …
…, AW Signell, HD Wilson, MT Kia Ik, J Seow… - PLoS …, 2020 - journals.plos.org
There is a clear requirement for an accurate SARS-CoV-2 antibody test, both as a complement
to existing diagnostic capabilities and for determining community seroprevalence. We …
to existing diagnostic capabilities and for determining community seroprevalence. We …
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
The coronaviral spike is the dominant viral antigen and the target of neutralizing antibodies.
We show that SARS-CoV-2 spike binds biliverdin and bilirubin, the tetrapyrrole products of …
We show that SARS-CoV-2 spike binds biliverdin and bilirubin, the tetrapyrrole products of …
[PDF][PDF] A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
J Seow, H Khan, A Rosa, V Calvaresi, C Graham… - Cell Reports, 2022 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike is the target for
neutralizing antibodies elicited following both infection and vaccination. While extensive research …
neutralizing antibodies elicited following both infection and vaccination. While extensive research …